SLC35C1 and central nervous system cancer: We found that the expression of SLC35C1 was significantly different between normal brain tissue and glioma, suggesting that SLC35C1 has a crucial role in the occurrence and development of glioma, which will provide new possibilities for the treatment of glioma6 As we have learned, critical analysis of tumor survival prognostic factors plays an important role in the formulation of clinical treatment decisions.